Point72 »

Ovid Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2025-09-30 $256 197 1.30
2025-06-30 $428 1.3k 0.33

More positions owned by Point72

Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Boston Scientific Corporation (BSX)
Amazon (AMZN)
Edwards Lifesciences (EW)
Integer Hldgs (ITGR)
Visa Com Cl A (V)
Applied Materials (AMAT)
McKesson Corporation (MCK)
Capital One Financial (COF)
Natera (NTRA)
Sotera Health (SHC)
Dex (DXCM)
Comcast Corp Cl A (CMCSA)

View all positions for Point72

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Vanguard Group
Affinity Asset Advisors
Acadian Asset Management
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Kennedy Capital Management
Ikarian Capital
Millennium Management
Assenagon Asset Management
Schonfeld Strategic Advisors
Marshall Wace
Wells Fargo & Company

View all funds holding Ovid Therapeutics